83
Participants
Start Date
December 4, 2019
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2029
Ipilimumab and nivolumab
The effect of ipilimumab and nivolumab has previously been tested in metastatic uveal melanoma. In this study the combination with percutaneous hepatic perfusion will be performed in order to evaluate the effect.
Melphalan chemosaturation via percutaneous hepatic perfusion
The effect of ipilimumab and nivolumab has previously been tested in metastatic uveal melanoma. In this study the combination with percutaneous hepatic perfusion will be performed in order to evaluate the effect.
Leiden University Medical Center, Leiden
Leiden University Medical Center
OTHER